Background: Microcystic lymphatic malformations (LMs) are congenital lesions with the diameter of the majority of cysts <1 cm. Bleomycin sclerotherapy has been shown to yield beneficial results for macrocystic LMs. This study aims to evaluate the safety and efficacy of consecutive bleomycin sclerotherapy for large diffuse microcystic LMs.
Methods: The location and size of the lesions were detected by ultrasound for the 46 patients included in this study. Bleomycin lavage was performed in larger cysts and intradermal injection for the superficial lesion. The outcome and complications were assessed for its efficacy and safety.
Results: The large diffuse microcystic LMs mainly located in the neck, abdominal wall and axilla/lateral chest wall. The average lesion size was 10.6 cm × 7.2 cm. The mean number of treatment sessions was 4.5 with 7.3 mg bleomycin for per session averagely. Excellent (69.6%) and moderate (23.9%) responses were obtained. There was no recurrence for the 6 patients (13%) who received a long follow-up. Obvious local swelling, slight intralesional hemorrhage and low-grade fever were the most commonly occurred complications. No lung fibrosis was identified for the patients who received more than 6 sessions.
Conclusions: Local lavage combined with intradermal injection of bleomycin is effective and safe for large diffuse microcystic LMs with good therapeutic effect and low complication rates, and can be regarded as the mainstay of therapy for microcystic LMs.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258892 | PMC |
http://dx.doi.org/10.21037/gs-21-70 | DOI Listing |
J Neurointerv Surg
January 2025
Interventional Radiology, Anhui Provincial Children's Hospital, Hefei, China.
Background: Lymphatic malformations (LMs) are low-flow, congenital lesions commonly presenting as asymptomatic masses in the head and neck. However, large lymphangiomas can significantly affect breathing or swallowing, posing considerable treatment challenges.
Methods: A retrospective analysis of complex cervicofacial LMs in infants was conducted over the past 8 years at the Department of Radiology.
Front Cell Dev Biol
December 2024
Department of Plastic Surgery, Jiangxi Provincial Children's Hospital, Nanchang, China.
Background: Over the past few decades, percutaneous sclerotherapy has been proven to be efficacy in treating macrocystic lymphatic malformations (LMs). Unfortunately, there still remains challenging in the treatment of microcystic LMs given their size. We introduce the intralesional laser thermolysis (ILT) technique, a novel enhancement technique for the traditional percutaneous sclerotherapy in the treatment of microcystic LMs.
View Article and Find Full Text PDFOtolaryngol Head Neck Surg
December 2024
Johns Hopkins University School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Objective: Examine the management and outcomes of pediatric head and neck lymphatic malformations (HNLMs).
Study Design: Retrospective case series.
Setting: Tertiary academic hospital.
Cureus
September 2024
Oral and Maxillofacial Surgery, Vinayaka Mission's Sankarachariyar Dental College, Vinayaka Mission's Research Foundation (Deemed to Be University), Salem, IND.
Hamartomatous lymphatic channel proliferation causes lymphangiomas or microcystic lymphatic malformations (MLM). They are most commonly found in the head and neck, with oral occurrences a rarity. In this case, a 34-year-old woman presented with lymphangioma circumscriptum on the buccal mucosa, a condition that typically causes asymptomatic pebbly papules.
View Article and Find Full Text PDFCancers (Basel)
October 2024
Department of Pathology, Peking University People's Hospital, Beijing 100044, China.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!